Patent · US Active

Aluminum compounds for use in therapeutics and vaccines

US9895437B2 · kind B2 · utility

1Cited by

5References

18Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Robert Schlegl · Siegenfeld, AT
Michael Möhlen · Marburg, DE
Jürgen Wruss · Wien, AT
Michael Weber · Wien, AT

Key dates

Filing date	Apr 18, 2012
Grant date	Feb 20, 2018
Priority date	—
Expiry date	Apr 18, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to means and methods for preparing aqueous composition comprising aluminum and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminum content. The invention further relates to aqueous compositions comprising a protein and an aluminum-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.